EAU Edu Platform on GU cancers
Upcoming event
EAU UROonco: A meeting steered by the EAU Section of Oncological Urology
Home
/
Erdafitinib in advanced or metastatic urothelial carcinoma
Back
Erdafitinib in advanced or metastatic urothelial carcinoma
2024-10-25
Our chief editor Dr. Benjamin Pradere (FR) talks to Prof. Eva Compérat (AU) on erdafitinib in the treatment of advanced or metastatic urothelial carcinoma.
Share:
Previous
Next
